Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Radiomic Profiling Of Glioblastoma: Identifying An Imaging Predictor Of Patient Survival With Improved Performance Over Established Clinical And Radiologic Risk Models.

P. Kickingereder, Sina Burth, Antje Wick, M. Goetz, Oliver Eidel, H. Schlemmer, Klaus Maier-Hein, W. Wick, M. Bendszus, A. Radbruch, D. Bonekamp
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Purpose To evaluate whether radiomic feature-based magnetic resonance (MR) imaging signatures allow prediction of survival and stratification of patients with newly diagnosed glioblastoma with improved accuracy compared with that of established clinical and radiologic risk models. Materials and Methods Retrospective evaluation of data was approved by the local ethics committee and informed consent was waived. A total of 119 patients (allocated in a 2:1 ratio to a discovery [n = 79] or validation [n = 40] set) with newly diagnosed glioblastoma were subjected to radiomic feature extraction (12 190 features extracted, including first-order, volume, shape, and texture features) from the multiparametric (contrast material-enhanced T1-weighted and fluid-attenuated inversion-recovery imaging sequences) and multiregional (contrast-enhanced and unenhanced) tumor volumes. Radiomic features of patients in the discovery set were subjected to a supervised principal component (SPC) analysis to predict progression-free survival (PFS) and overall survival (OS) and were validated in the validation set. The performance of a Cox proportional hazards model with the SPC analysis predictor was assessed with C index and integrated Brier scores (IBS, lower scores indicating higher accuracy) and compared with Cox models based on clinical (age and Karnofsky performance score) and radiologic (Gaussian normalized relative cerebral blood volume and apparent diffusion coefficient) parameters. Results SPC analysis allowed stratification based on 11 features of patients in the discovery set into a low- or high-risk group for PFS (hazard ratio [HR], 2.43; P = .002) and OS (HR, 4.33; P < .001), and the results were validated successfully in the validation set for PFS (HR, 2.28; P = .032) and OS (HR, 3.45; P = .004). The performance of the SPC analysis (OS: IBS, 0.149; C index, 0.654; PFS: IBS, 0.138; C index, 0.611) was higher compared with that of the radiologic (OS: IBS, 0.175; C index, 0.603; PFS: IBS, 0.149; C index, 0.554) and clinical risk models (OS: IBS, 0.161, C index, 0.640; PFS: IBS, 0.139; C index, 0.599). The performance of the SPC analysis model was further improved when combined with clinical data (OS: IBS, 0.142; C index, 0.696; PFS: IBS, 0.132; C index, 0.637). Conclusion An 11-feature radiomic signature that allows prediction of survival and stratification of patients with newly diagnosed glioblastoma was identified, and improved performance compared with that of established clinical and radiologic risk models was demonstrated. (©) RSNA, 2016 Online supplemental material is available for this article.
This paper references
10.1016/S1361-8415(01)00036-6
A global optimisation method for robust affine registration of brain images
M. Jenkinson (2001)
10.1038/ncomms5006
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
10.1002/mrm.10522
Tracer arrival timing‐insensitive technique for estimating flow in MR perfusion‐weighted imaging using singular value decomposition with a block‐circulant deconvolution matrix
O. Wu (2003)
10.1200/JCO.2009.26.3541
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
P. Wen (2010)
10.1148/radiol.14131731
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
O. Gevaert (2014)
10.1109/TMI.2010.2046908
N4ITK: Improved N3 Bias Correction
N. Tustison (2010)
10.1002/jmri.23600
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)‐MRI estimates of cerebral blood volume (CBV) in human gliomas
B. Ellingson (2012)
10.1093/neuonc/nov028
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
P. Kickingereder (2015)
10.1093/annonc/mdu173
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
L. De Cecco (2014)
10.3174/ajnr.A4284
Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas
G. Çoban (2015)
10.1371/journal.pbio.0020108
Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data
E. Bair (2004)
10.1111/J.1541-0420.2007.00832.X
Efron-type measures of prediction error for survival analysis.
T. Gerds (2007)
10.3174/ajnr.A3837
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
A. Hilário (2014)
10.1200/JCO.2012.45.5626
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
A. Pellagatti (2013)
10.1093/bioinformatics/btm232
Assessment of survival prediction models based on microarray data
M. Schumacher (2007)
10.1093/bioinformatics/btn458
Supervised principal component analysis for gene set enrichment of microarray data with continuous or survival outcomes
X. Chen (2008)
10.1093/neuonc/nou223
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.
Q. Ostrom (2014)
10.18637/JSS.V050.I11
Evaluating Random Forests for Survival Analysis using Prediction Error Curves.
U. Mogensen (2012)
10.1007/s11548-013-0840-8
The Medical Imaging Interaction Toolkit: challenges and advances
M. Nolden (2013)
10.1148/radiol.2015151172
MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
P. Kickingereder (2016)
10.1016/j.neuroimage.2006.01.015
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
P. Yushkevich (2006)
10.1148/radiol.14132740
Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
P. Kickingereder (2014)
10.1002/jmri.20039
Survival analysis in patients with glioblastoma multiforme: Predictive value of choline‐to‐n‐acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume
J. Oh (2004)
10.1126/scitranslmed.aaa7582
Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities
Haruka Itakura (2015)
10.1002/MRM.1910360510
High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis
L. Østergaard (1996)
10.1073/pnas.1505935112
Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images
D. Fehr (2015)
10.1148/radiol.2015151169
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
10.1148/radiol.15142698
Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
S. Yamamoto (2015)
10.1002/jmri.24756
Association of overall survival in patients with newly diagnosed glioblastoma with contrast‐enhanced perfusion MRI: Comparison of intraindividually matched T1‐ and T2*‐based bolus techniques
D. Bonekamp (2015)
10.1158/1078-0432.CCR-13-0017
Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations
C. Hartmann (2013)
10.1198/016214505000000628
Prediction by Supervised Principal Components
E. Bair (2006)
10.1109/42.668698
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
J. Sled (1998)
10.1002/hbm.10062
Fast robust automated brain extraction
S. Smith (2002)
10.1002/mrm.20759
Automatic selection of arterial input function using cluster analysis
K. Mouridsen (2006)
10.1007/s00401-007-0243-4
The 2007 WHO Classification of Tumours of the Central Nervous System
D. N. Louis (2007)
10.1148/radiol.2472070898
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
M. Law (2008)
10.1016/j.nicl.2014.08.008
Statistical normalization techniques for magnetic resonance imaging☆☆☆
R. Shinohara (2014)
10.1148/RADIOL.2432060450
Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
R. Murakami (2007)



This paper is referenced by
10.1089/OMI.2017.0087
Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation
KatsilaTheodora (2017)
10.1016/j.canrad.2020.07.005
Use of radiomics in the radiation oncology setting: Where do we stand and what do we need?
U. Schick (2020)
10.18466/CBAYARFBE.384729
Fully Automated and Adaptive Intensity Normalization Using Statistical Features for Brain MR Images
E. Goceri (2018)
10.3174/ajnr.A5858
Shape Features of the Lesion Habitat to Differentiate Brain Tumor Progression from Pseudoprogression on Routine Multiparametric MRI: A Multisite Study
M. Ismail (2018)
10.1016/j.diii.2018.11.007
Ovarian cancer: An update on imaging in the era of radiomics.
S. Nougaret (2018)
10.1109/IJCNN48605.2020.9207031
Interpreting response to TMZ therapy in murine GL261 glioblastoma by combining Radiomics, Convex-NMF and feature selection in MRI/MRSI data analysis
Luis Miguel Núñez (2020)
10.1038/s41598-020-61178-w
Radiomics prognostication model in glioblastoma using diffusion- and perfusion-weighted MRI
J. Park (2020)
10.1002/cam4.1672
Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas
X. Liu (2018)
10.1093/annonc/mdz108
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S. Trebeschi (2019)
10.1371/journal.pone.0217785
Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals
Y. Choi (2019)
10.1007/s00330-017-5154-8
A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images
Zijian Zhang (2017)
10.18632/aging.101594
Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
Z. Qian (2018)
10.1007/s00330-020-06737-5
Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction
Y. S. Choi (2020)
10.1093/neuonc/noz004
Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging
E. Gates (2019)
10.7150/thno.48027
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images
P. Tian (2021)
10.1007/s00330-017-4964-z
MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis
Y. Li (2017)
10.1088/1361-6560/ab489f
A multi-organ cancer study of the classification performance using 2D and 3D image features in radiomics analysis.
L. Xu (2019)
10.1117/12.2255694
Radiogenomic analysis of hypoxia pathway reveals computerized MRI descriptors predictive of overall survival in glioblastoma
N. Beig (2017)
10.1117/12.2512995
Investigating a quantitative radiomics approach for brain tumor classification
Anas Z. Abidin (2019)
10.18383/j.tom.2018.00033
Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space
Sean D. McGarry (2019)
10.1016/j.tranon.2017.09.003
MRI Texture Analysis Reflects Histopathology Parameters in Thyroid Cancer – A First Preliminary Study
H. Meyer (2017)
10.1007/s00066-020-01626-8
Applications of radiomics and machine learning for radiotherapy of malignant brain tumors
M. Kocher (2020)
10.1007/978-3-030-27359-0_7
Parametric Response Map (PRM) Analysis Improves Response Assessment in Gliomas
M. Cárdenas (2020)
10.1007/s00330-018-5830-3
Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging
Y. Park (2018)
10.1007/s00261-019-01929-0
Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT
H. Coy (2019)
10.1038/s41598-018-37387-9
Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages
Dong Nie (2019)
10.1007/978-3-030-27359-0
Glioma Imaging: Physiologic, Metabolic, and Molecular Approaches
W. Pope (2020)
10.1007/s11517-018-1858-4
Prediction of survival with multi-scale radiomic analysis in glioblastoma patients
A. Chaddad (2018)
10.3389/fncom.2020.00061
Overall Survival Prediction in Glioblastoma With Radiomic Features Using Machine Learning
Ujjwal Baid (2020)
10.3348/JKSR.2020.81.3.467
뇌종양 영상의 현재와 미래
박 지은 (2020)
10.1093/noajnl/vdaa146
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram
S. Ferguson (2021)
Benchmarking features from different radiomics toolkits / toolboxes using Image Biomarkers Standardization Initiative
Mingxi Lei (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar